Todd Nelson

SGI-DNA has appointed Todd Nelson as CEO to lead its spin out from Synthetic Genomics. Nelson has led several life sciences companies through phases of financial and commercial growth, including eBioscience (which was acquired by Affymetrix), MP Biomedicals (which was acquired by Valeant Fine Chemicals), and DiscoverX Corporation (now Eurofins), SGI-DNA said. He is also the founder of Tonbo Biosciences and TCRx Corporation.